Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of agomelatine 25 mg under fasting conditions in healthy volunteers
TCTR20200903006Completed
- Sponsor
- Unison Laboratories
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of agomelatine (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 2 more. Started Nov 2020; status: completed.
02
Drugs
agomelatine
Beyond the preview
Go deeper on TCTR20200903006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200903006.